COVID-19-associated fungal infections

M Hoenigl, D Seidel, R Sprute, C Cunha… - Nature …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial

L Millon, D Caillot, A Berceanu… - Clinical Infectious …, 2022 - academic.oup.com
Background Early diagnosis and prompt initiation of specific antifungal treatment are
essential for improving the prognosis of mucormycosis. We aimed to assess the …

Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?

S Dellière, E Dudoignon, S Voicu, M Collet… - Journal of Clinical …, 2022 - Am Soc Microbiol
Diagnosis of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis
(CAPA) remains unclear especially in nonimmunocompromised patients. The aim of this …

Microbiological and molecular diagnosis of mucormycosis: from old to new

N Lackner, W Posch, C Lass-Flörl - Microorganisms, 2021 - mdpi.com
Members of the order Mucorales may cause severe invasive fungal infections
(mucormycosis) in immune-compromised and otherwise ill patients. Diagnosis of Mucorales …

Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the Fungal Diagnostics Laboratories Consortium (FDLC)

SX Zhang, NE Babady, KE Hanson… - Journal of clinical …, 2021 - Am Soc Microbiol
Fungal infections are a rising threat to our immunocompromised patient population, as well
as other nonimmunocompromised patients with various medical conditions. However, little …

An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections

JD Jenks, PL White, SE Kidd, T Goshia… - Expert Review of …, 2023 - Taylor & Francis
Background Invasive fungal infections cause millions of infections annually, but diagnosis
remains challenging. There is an increased need for low-cost, easy to use, highly sensitive …

Epidemiology, modern diagnostics, and the management of mucorales infections

D Pham, AR Howard-Jones, R Sparks, M Stefani… - Journal of Fungi, 2023 - mdpi.com
Mucormycosis is an uncommon, yet deadly invasive fungal infection caused by the
Mucorales moulds. These pathogens are a WHO-assigned high-priority pathogen group, as …

Liposomal amphotericin B—the present

J Maertens, L Pagano, E Azoulay… - Journal of Antimicrobial …, 2022 - academic.oup.com
Most invasive fungal infections are opportunistic in nature but the epidemiology is constantly
changing, with new risk groups being identified. Neutropenia is a classical risk factor for …

Emerging diagnostics and therapeutics for invasive fungal infections

DZP Friedman, IS Schwartz - Infectious Disease Clinics, 2023 - id.theclinics.com
The number of patients at risk for fungal infections continues to increase because of
improved survival of medically and surgically complex patients, new indications for …